⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 29, 2018Journal of Clinical OncologyOpen Access

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

View Full Paper

Ask AI

Bookmark

Share

Authors

JBJennifer N. BrudnoNational Institutes of Health IMIrina MarićNovartis (Switzerland)SHSteven D. HartmanMount Sinai Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brudno et al. (2018) studied this question.

synapsesocial.com/papers/6a7d00c5f1daba58ecd59d0d https://doi.org/10.1200/jco.2018.77.8084

View Full Paper

Ask AI

Bookmark

Share